Is the US prepared to deal with another pandemic or widespread health crisis?
Short answer: Better than in 2020, but not “ready enough.” Since COVID‑19 the U.S. has built real capabilities, yet independent oversight still flags critical gaps that could slow an early, decisive response to the next large outbreak.
What’s stronger now
Where we’re still vulnerable
Bottom line
If helpful, tell me your state or sector (e.g., hospital, school, city government), and I can summarize what these changes mean for your local readiness and where to focus next.
Citations (10)
- https://uscode.house.gov/view.xhtml?edition=2023&req=granuleid%3AUSC-2023-title42-chapter6A-subchapter26&saved=%7CZ3JhbnVsZWlkOlVTQy0yMDIzLXRpdGxlNDItY2hhcHRlcjZBLXN1YmNoYXB0ZXIyNi1wYXJ0QS1mcm9udA%3D%3D%7C%7C%7C0%7Cfalse%7C2023
Backs: “Congress created a permanent White House Office of Pandemic Preparedness and Response Policy to coordinate across agencies; the Administration published a preparedness “roadmap” in January 2025.”
- CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health Threats | CDC Online Newsroom | CDC
Backs: “CDC also stood up the Center for Forecasting and Outbreak Analytics for season outlooks and near‑term forecasts.”
- Progress and Expansion of the National Wastewater Surveillance System, United States, 2020–2024
Backs: “The National Wastewater Surveillance System expanded to track SARS‑CoV‑2, influenza A, and RSV nationally, and CDC reported major growth in sites and targets through 2024, improving “early warning” capacity.”
- Medical Countermeasures | Project NextGen: Next Generation Medical Countermeasures
Backs: “BARDA continues to fund next‑generation vaccines, therapeutics, and diagnostics (e.g., through Project NextGen) and reported additional FDA clearances and approvals in 2024–2025.”
- FY 2026 CDC Congressional Justification
Backs: “Multi‑year cooperative agreements remain in place—the CDC PHEP program (public health departments) and ASPR’s HPP (health‑care coalitions/hospitals)—to fund planning, exercises, and surge readiness through 2028–2029.”
- National Milk Testing Strategy | Animal and Plant Health Inspection Service
Backs: “During the H5N1 detections in U.S. dairy cattle (2024→), USDA/CDC implemented testing and movement controls (including a National Milk Testing Strategy) and tracked human exposures—evidence the U.S. can coordinate across animal and human health systems.”
- GAO-25-107743, HIGH-RISK SERIES: Heightened Attention to High-Risk Areas Could Yield Billions in Savings and A More Efficient and Effective Government
Backs: “GAO kept HHS leadership/coordination for public‑health emergencies on its 2025 High‑Risk List, citing persistent coordination and execution problems.”
- Public Health Preparedness: HHS Needs a Coordinated National Approach for Diagnostic Testing for Pandemic Threats | U.S. GAO
Backs: “GAO (2025) found HHS still needs a coordinated national strategy for diagnostics—rapid test development, deployment, and data reporting—updated from COVID‑era lessons.”
- Public Health Preparedness: Experts Identified Actions to Improve Surveillance for Emerging Disease Threats | U.S. GAO
Backs: “Experts convened by GAO (2025–2026) identified actions to improve emerging‑threat surveillance and data sharing; wastewater coverage still varies by state and season.”
- Public Health Preparedness: HHS Should Address Strategic National Stockpile Coordination Challenges | U.S. GAO
Backs: “HHS issued new guidance to clarify Strategic National Stockpile roles (July 2025) and a broader SNS strategy, but GAO says coordination and requirement‑setting need continued follow‑through.”